Doximity, Inc.DD

Doximity, Inc.

66.07USDR
−0.27−0.41%
Last update at 22:47 GMT
USD
No tradesPost-market
See on Supercharts
Next report date
May 20
Report period
Q4 2024
EPS estimate
0.27 USD
Revenue estimate
‪134.02 M‬ USD
Market capitalization
‪12.40 B‬USD
1.08USD
‪147.58 M‬USD
‪475.42 M‬USD
‪129.64 M‬
Beta (1Y)
1.89
Employees (FY)
827
Change (1Y)
−150 −15.35%
Revenue / Employee (1Y)
‪574.88 K‬USD
Net income / Employee (1Y)
‪178.45 K‬USD

About Doximity, Inc.


CEO
Jeffrey A. Tangney
Headquarters
San Francisco
Founded
2010
FIGI
BBG0026ZJQX7
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.
Performance
‪30%‬
‪34%‬
‪38%‬
‪42%‬
‪46%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪45.00 M‬‬
‪‪90.00 M‬‬
‪‪135.00 M‬‬
‪‪180.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪45.00 M‬‬
‪‪90.00 M‬‬
‪‪135.00 M‬‬
‪‪180.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪45.00 M‬‬
‪‪90.00 M‬‬
‪‪135.00 M‬‬
‪‪180.00 M‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 20, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.12‬
‪0.24‬
‪0.36‬
‪0.48‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DOCS is 66.07 USD — it has decreased by −0.41% in the past 24 hours. Watch Doximity, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Doximity, Inc. stocks are traded under the ticker DOCS.
DOCS stock has risen by 3.82% compared to the previous week, the month change is a −11.43% fall, over the last year Doximity, Inc. has showed a 136.89% increase.
We've gathered analysts' opinions on Doximity, Inc. future price: according to them, DOCS price has a max estimate of 90.00 USD and a min estimate of 55.00 USD. Watch DOCS chart and read a more detailed Doximity, Inc. stock forecast: see what analysts think of Doximity, Inc. and suggest that you do with its stocks.
DOCS reached its all-time high on Sep 10, 2021 with the price of 107.79 USD, and its all-time low was 19.71 USD and was reached on Sep 25, 2023. View more price dynamics on DOCS chart.
See other stocks reaching their highest and lowest prices.
DOCS stock is 3.75% volatile and has beta coefficient of 1.89. Track Doximity, Inc. stock price on the chart and check out the list of the most volatile stocks — is Doximity, Inc. there?
Today Doximity, Inc. has the market capitalization of ‪12.45 B‬, it has increased by 3.11% over the last week.
Yes, you can track Doximity, Inc. financials in yearly and quarterly reports right on TradingView.
Doximity, Inc. is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
DOCS earnings for the last quarter are 0.45 USD per share, whereas the estimation was 0.34 USD resulting in a 33.37% surprise. The estimated earnings for the next quarter are 0.27 USD per share. See more details about Doximity, Inc. earnings.
Doximity, Inc. revenue for the last quarter amounts to ‪168.60 M‬ USD, despite the estimated figure of ‪152.82 M‬ USD. In the next quarter, revenue is expected to reach ‪134.02 M‬ USD.
DOCS net income for the last quarter is ‪75.20 M‬ USD, while the quarter before that showed ‪44.15 M‬ USD of net income which accounts for 70.30% change. Track more Doximity, Inc. financial stats to get the full picture.
No, DOCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 25, 2025, the company has 827.00 employees. See our rating of the largest employees — is Doximity, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Doximity, Inc. EBITDA is ‪234.35 M‬ USD, and current EBITDA margin is 38.50%. See more stats in Doximity, Inc. financial statements.
Like other stocks, DOCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Doximity, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Doximity, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Doximity, Inc. stock shows the buy signal. See more of Doximity, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.